Hp. Breuel et al., PHARMACOKINETIC INTERACTIONS BETWEEN LITHIUM AND FLUOXETINE AFTER SINGLE AND REPEATED FLUOXETINE ADMINISTRATION IN YOUNG HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 33(7), 1995, pp. 415-419
Pharmacokinetic interactions following coadministration of fluoxetine
and lithium were investigated in 10 young healthy subjects. Both drugs
were administered orally in a non-blinded design with 3 consecutive t
reatment periods: single oral dose of Lithium (32.4 mmol lithium as ac
etate, Quilonum; coadministration of single oral doses of lithium (32.
4 mmol) and fluoxetine (Fluctin, 60 mg); and single oral dose of lithi
um after 7-day pretreatment with fluoxetine (20 mg t.i.d.). Periods 1
and 2 were separated by a 1-week washout phase, while period 3 followe
d on immediately after period 2. Lithium serum concentrations were pra
ctically identical in periods 1 and 3 (administration of lithium alone
and after chronic fluoxetine dosing). However, in period 2, when the
2 drugs were coadministered as single oral doses, the lithium concentr
ations were lower in the first 4 hours after medication compared with
treatment periods 1 and 3. C-max was also significantly lower in perio
d 2. The times to peak, however, were not significantly changed by any
fluoxetine comedication. The parameters AUC(0-infinity), t(1/2), tota
l clearance (Cl-tot) and renal clearance (Cl-ren) determined after adm
inistration of Lithium alone did not differ statistically from values
determined after single or after repeated fluoxetine dosing. Coadminis
tration of lithium and fluoxetine did not produce any clinically relev
ant changes in hemodynamics, ECGs or laboratory parameters. After sing
le doses of both drugs the most frequently reported symptoms were gast
rointestinal complaints, while mild sedative symptoms were predominant
when lithium was given after repeated fluoxetine medication. In concl
usion, the findings of this study indicate that the reported occurrenc
e of neurotoxic symptoms after lithium augmentation of unsuccessful tr
eatment with fluoxetine is not due to a pharmacokinetic interaction re
sulting in modified lithium kinetics.